Technology News and Research

RSS

Cyntellect to provide LEAP Cell Processing Workstation to Salk Institute for Biological Studies

Cyntellect, Inc., a privately-held life sciences company commercializing products to advance the study of cell biology, stem cell research, biopharmaceutical production, and drug discovery, has entered into an agreement with the Salk Institute for Biological Studies to provide its researchers with the LEAP™ Cell Processing Workstation.

16 Jun 2010

Global drug distribution programs one factor in hastening drug resistance, report says

A Center for Global Development (CGD) report released Tuesday details factors leading to increased drug resistance worldwide, including drug distribution programs in developing countries, Reuters reports.

16 Jun 2010

Menicon announces acquisition of Lagado

Menicon Co., Ltd. announced on June 16 that Menicon and Lagado Corporation based in Colorado, USA, reached an agreement for Lagado to become a wholly owned subsidiary of Menicon America Inc., effective as of June 14, 2010.

16 Jun 2010

ISB, GIND collaborate on whole-genome sequencing to identify drug targets for Huntington's Disease

The Institute for Systems Biology (ISB) of Seattle, WA, is collaborating with the Gladstone Institute of Neurological Disease (GIND) and its Taube-Koret Center for Huntington's Disease Research to use whole-genome sequencing to identify genes and novel drug targets related to the onset and progression of Huntington's disease (HD). The research team, led by GIND associate director and senior investigator Steven Finkbeiner, MD, PhD, will also use induced pluripotent stem (iPS) cells from patients with HD to screen for drugs that might delay, prevent, or even reverse this devastating condition.

16 Jun 2010

Sapient Discovery, Helicon Therapeutics enter structural biology collaboration

Sapient Discovery, LLC., a structure-guided drug discovery company, announced today that it has entered into a research collaboration agreement with the Helicon Therapeutics, Inc., a San Diego based pharmaceutical company. Under the terms of the agreement, Sapient Discovery will apply its proprietary structural biology platform and expertise to determine the three-dimensional structures for targets of interest to Helicon Therapeutics, Inc.

16 Jun 2010

Cancer overtreatment raises concern; Physicians tend to use new technology even before solid evidence backs it

The Associated Press/Arizona Republic: "It's an unthinkable notion for a generation raised on the message that early cancer detection saves lives, but specialists say more tumors actually are being found too early. That is raising uncomfortable questions about how aggressively to treat early growths -- in some cases, even how aggressively to test -- along with a push for more of the informed-choice programs.

16 Jun 2010

LMBRI, Lipopharma Therapeutics collaborate to promote cancer drug development, improve patient outcomes

LMBRI LLC and Lipopharma Therapeutics SL today announced collaboration aimed at transforming cancer drug development and improving patient outcomes. Lipopharma developed new assessment approaches, methods and technologies for developing cancer therapeutics and diagnostics using their proprietary design of structure-based molecules that regulate the structure and functions of the membrane lipids, instead targeting cellular proteins, called "Membrane Lipid-Therapy".

16 Jun 2010

FDA clears Halt 2000GI Electrosurgical System for soft tissue ablation

Halt Medical, Inc., today announced that the U.S. Food and Drug Administration (FDA) has cleared the Halt 2000GI™ Electrosurgical System for soft tissue ablation using radiofrequency energy. "This clearance to market is a major milestone for our customers, employees and investors," said Russ DeLonzor, President and Chief Operating Officer.

16 Jun 2010

TYRX successfully implants AIGISRx device in 10,000 patients in the U.S.

TYRX, Inc. announced today that it has successfully implanted its AIGISRx device in 10,000 patients in the United States. The AIGISRx device is an antibacterial mesh technology that securely holds a pacemaker or implantable cardioverter defibrillator in place to create a stable environment, while delivering antimicrobial agents, rifampin and minocycline. These antimicrobial agents have been shown to reduce infections associated with medical devices in multiple randomized controlled trials.

15 Jun 2010

BIOTRONIK announces commercial availability of new ProMRI Pacing Systems

BIOTRONIK SE & Co. KG, a leading manufacturer of high-quality implantable cardiac devices and pioneer of wireless remote monitoring technologies, announced today the commercial availability of its new ProMRI Pacing Systems — Evia pacemaker series and Safio pacing leads — providing European patients the first portfolio of bradycardia systems that are compatible with Magnetic Resonance Imaging scans under specific conditions.

15 Jun 2010

Epocal receives FDA marketing clearance for new lactate test on epoc Blood Analysis System

Epocal, Inc., a leading edge provider of point of care technology, announced today that it has received U.S. Food and Drug Administration (FDA) clearance to market its new lactate test on the epoc Blood Analysis System. Lactate measurements from the epoc System are used to evaluate acid-base status and for diagnosis and treatment of lactic acidosis (abnormally high acidity of the blood).

15 Jun 2010

CLC bio headed molecular diagnostics project receives $2M grant

CLC bio, Ion Torrent, and Aarhus University Hospital - Departments of Molecular Medicine and Clinical Genetics, have received a 2 million USD grant from the Danish National Advanced Technology Foundation.

15 Jun 2010

Sensory-tested flavors for coconut water formulations

WILD Flavors, Inc. continues to be innovative in product and flavoring offerings, and has expanded into the coconut water trend through the research and development of not only flavors that test well in coconut water applications, but in new marketable concepts that utilize coconut water. As consumers grow to love the health benefits of coconut water - so will their taste palettes, especially when paired with WILD's sensory-tested flavors for coconut water formulations.

15 Jun 2010

U.S. video, high-tech and integrated OR equipment market to exceed $2 billion by 2016

According to a new report by iData Research, the leading global authority in medical device and pharmaceutical market research, the overall U.S. video, high-tech and integrated operating room (OR) equipment market was worth $1.49 billion in 2009. This market, which experienced a strong decline during the economic recession, is expected to recover, exceeding $2 billion by 2016.

15 Jun 2010

Kendle offers BNA imaging technology for monitoring brain electro-physiological network activity

Kendle, a leading, global full-service clinical research organization, today announced it now offers Brain Network Activation imaging providing a non-invasive platform for mapping, monitoring and understanding brain electro-physiological network activity in response to cognitive or physiological stimuli. The BNA imaging technology was developed by ElMindA, a medical technology development company based in Herzliya, Israel.

15 Jun 2010

Viking's Next Generation 3DHD Visualization System presented at Laparoscopy and Robotics congress

Viking Systems, Inc. announced today that its Next Generation 3DHD Visualization System was presented June 10th at The European Congress of Laparoscopy and Robotics by Dr. Gunter Janetschek, Professor and Chairman, Department of Urology, Medical University Salzburg, as part of his talk "Is there a future beyond 'da Vinci'?"

15 Jun 2010

DATATRAK premieres Safety Case Manager at 46th Annual DIA Meeting

DATATRAK International, Inc., a technology and services company focused on global eClinical solutions for the clinical trials industry, premiered the release of its safety system Monday at the 46th Annual DIA Meeting. The DATATRAK Safety Case Manager™ collects individual case safety report (ICSR) data and exports the data in E2B XML format for transmission to regulatory authorities.

15 Jun 2010

Sonomax licenses V4 technology to Creare

Sonomax Technologies Inc. is pleased to announce that it has signed its first licensing deal whereby its groundbreaking V4 technology has been licensed to Creare Inc. (Creare) for use in a Research and Development (R&D) project being executed on behalf of the United States Navy. If the synergy of Creare and Sonomax produces a product or technology that can be commercialized, then it is agreed that both parties will work together to explore opportunities to jointly license the combined technology.

15 Jun 2010

Endosense launches ProForce Registry Study of TactiCath force-sensing ablation catheter

Endosense, a medical technology company focused on improving the efficacy, safety and reproducibility of catheter ablation for the treatment of cardiac arrhythmias, has announced enrollment of the first patients in its ProForce Registry. The news marks the launch of the ProForce Registry Study, an international, single arm, multi-center, post-market trial of Endosense's TactiCath force-sensing ablation catheter.

15 Jun 2010

AMRI announces acquisition of Hyaluron

AMRI today announced the acquisition of Hyaluron Inc., expanding AMRI's contract manufacturing capabilities to include cGMP manufacturing and sterile filling of parenteral drugs to the biopharmaceutical industry. AMRI has acquired all facilities and equipment as well as a highly trained and experienced staff of professionals with expertise in sterile GMP manufacturing. Purchase price, including debt, was approximately $27 million.

15 Jun 2010

Technology News and Research

Cyntellect to provide LEAP Cell Processing Workstation to Salk Institute for Biological Studies

Global drug distribution programs one factor in hastening drug resistance, report says

Menicon announces acquisition of Lagado

ISB, GIND collaborate on whole-genome sequencing to identify drug targets for Huntington's Disease

Sapient Discovery, Helicon Therapeutics enter structural biology collaboration

Cancer overtreatment raises concern; Physicians tend to use new technology even before solid evidence backs it

LMBRI, Lipopharma Therapeutics collaborate to promote cancer drug development, improve patient outcomes

FDA clears Halt 2000GI Electrosurgical System for soft tissue ablation

TYRX successfully implants AIGISRx device in 10,000 patients in the U.S.

BIOTRONIK announces commercial availability of new ProMRI Pacing Systems

Epocal receives FDA marketing clearance for new lactate test on epoc Blood Analysis System

CLC bio headed molecular diagnostics project receives $2M grant

Sensory-tested flavors for coconut water formulations

U.S. video, high-tech and integrated OR equipment market to exceed $2 billion by 2016

Kendle offers BNA imaging technology for monitoring brain electro-physiological network activity

Viking's Next Generation 3DHD Visualization System presented at Laparoscopy and Robotics congress

DATATRAK premieres Safety Case Manager at 46th Annual DIA Meeting

Sonomax licenses V4 technology to Creare

Endosense launches ProForce Registry Study of TactiCath force-sensing ablation catheter

AMRI announces acquisition of Hyaluron

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Advancing Intracellular Delivery with LumiPore®

Latest News